Faculty of Pharmaceutical Sciences, Hokkaido University, Kita 12 Nishi 6, Sapporo City, Hokkaido, 060-0812, Japan.
Adv Biochem Eng Biotechnol. 2010;119:197-230. doi: 10.1007/10_2008_40.
In this review we introduce a new concept for developing a nonviral gene delivery system which we call "Programmed Packaging." Based on this concept, we succeeded in developing a multifunctional envelope-type nano device (MEND), which exerts high transfection activities equivalent to those of an adenovirus in a dividing cell. The use of MEND has been extended to in vivo applications. PEG/peptide/DOPE ternary conjugate (PPD)-MEND, a new in vivo gene delivery system for the targeting of tumor cells that dissociates surface-modified PEG in tumor tissue by matrix metalloproteinase (MMP) and exerts significant transfection activities, was developed. In parallel with the development of MEND, a quantitative gene delivery system, Confocal Image-assisted 3-dimensionally integrated quantification (CIDIQ), also was developed. This method identified the rate-limiting step of the nonviral gene delivery system by comparing it with adenoviral-mediated gene delivery. The results of this analysis provide a new direction for the development of rational nonviral gene delivery systems.
在这篇综述中,我们介绍了一种开发非病毒基因传递系统的新概念,我们称之为“程序化包装”。基于这一概念,我们成功地开发了一种多功能包膜型纳米装置(MEND),它在分裂细胞中发挥的转染活性与腺病毒相当。MEND 的应用已扩展到体内应用。我们开发了一种新的体内基因传递系统,即聚乙二醇/肽/二油酰磷脂酰乙醇胺(PPD)-MEND,该系统通过基质金属蛋白酶(MMP)将肿瘤组织中表面修饰的 PEG 解离,并发挥显著的转染活性,用于靶向肿瘤细胞。与 MEND 的开发并行,我们还开发了一种定量基因传递系统,即共聚焦图像辅助的三维集成定量(CIDIQ)。该方法通过与腺病毒介导的基因传递进行比较,确定了非病毒基因传递系统的限速步骤。该分析的结果为合理的非病毒基因传递系统的发展提供了新的方向。